Abstract
Multiple large-scale epidemiological studies have identified obesity as an important risk factor for a variety of human cancers, particularly cancers of the uterus, gallbladder, kidney, liver, colon, and ovary, but there is much uncertainty regarding how obesity increases the cancer risks. Given that obesity has been consistently identified as a major risk factor for uterine tumors, the most common malignancies of the female reproductive system, we use uterine tumors as a pathological context to survey the relevant literature and propose a novel hypothesis: chronic downregulation of the cyclin-dependent kinase 8 (CDK8) module, composed of CDK8 (or its paralog CDK19), Cyclin C, MED12 (or MED12L), and MED13 (or MED13L), by elevated insulin or insulin-like growth factor signaling in obese women may increase the chances to dysregulate the activities of transcription factors regulated by the CDK8 module, thereby increasing the risk of uterine tumors. Although we focus on endometrial cancer and uterine leiomyomas (or fibroids), two major forms of uterine tumors, our model may offer additional insights into how obesity increases the risk of other types of cancers and diseases. To illustrate the power of model organisms for studying human diseases, here we place more emphasis on the findings obtained from Drosophila melanogaster.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adler AS, McCleland ML, Truong T, Lau S, Modrusan Z, Soukup TM, Roose-Girma M, Blackwood EM, Firestein R (2012) CDK8 maintains tumor dedifferentiation and embryonic stem cell pluripotency. Cancer Res 72:2129–2139
Ajabnoor GMA, Mohammed NA, Banaganapalli B, Abdullah LS, Bondagji ON, Mansouri N, Sahly NN, Vaidyanathan V, Bondagji N, Elango R et al (2018) Expanded somatic mutation Spectrum of MED12 gene in uterine leiomyomas of Saudi Arabian Women. Front Genet 9:552
Akoulitchev S, Chuikov S, Reinberg D (2000) TFIIH is negatively regulated by cdk8-containing mediator complexes. Nature 407:102–106
Al-Hendy A, Laknaur A, Diamond MP, Ismail N, Boyer TG, Halder SK (2017) Silencing Med12 gene reduces proliferation of human leiomyoma cells mediated via Wnt/beta-catenin signaling pathway. Endocrinology 158:592–603
Alarcon C, Zaromytidou AI, Xi Q, Gao S, Yu J, Fujisawa S, Barlas A, Miller AN, Manova-Todorova K, Macias MJ et al (2009) Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139:757–769
Aleman A, Rios M, Juarez M, Lee D, Chen A, Eivers E (2014) Mad linker phosphorylations control the intensity and range of the BMP-activity gradient in developing Drosophila tissues. Sci Rep 4:6927
Allen BL, Taatjes DJ (2015) The mediator complex: a central integrator of transcription. Nat Rev Mol Cell Biol 16:155–166
Ashrafian H, Harling L, Darzi A, Athanasiou T (2013) Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions? Metab Brain Dis 28:341–353
Ashworth A, Lord CJ, Reis-Filho JS (2011) Genetic interactions in cancer progression and treatment. Cell 145:30–38
Audetat KA, Galbraith MD, Odell AT, Lee T, Pandey A, Espinosa JM, Dowell RD, Taatjes DJ (2017) A kinase-independent role for cyclin-dependent kinase 19 in p53 response. Mol Cell Biol 37:e00626-16
Bancerek J, Poss ZC, Steinparzer I, Sedlyarov V, Pfaffenwimmer T, Mikulic I, Dolken L, Strobl B, Muller M, Taatjes DJ et al (2013) CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response. Immunity 38:250–262
Bar-Peled L, Sabatini DM (2014) Regulation of mTORC1 by amino acids. Trends Cell Biol 24:400–406
Barette C, Jariel-Encontre I, Piechaczyk M, Piette J (2001) Human cyclin C protein is stabilized by its associated kinase cdk8, independently of its catalytic activity. Oncogene 20:551–562
Belakavadi M, Fondell JD (2006) Role of the mediator complex in nuclear hormone receptor signaling. Rev Physiol Biochem Pharmacol 156:23–43
Bell DW, Ellenson LH (2019) Molecular genetics of endometrial carcinoma. Annu Rev Pathol 14:339–367
Bertsch E, Qiang W, Zhang Q, Espona-Fiedler M, Druschitz S, Liu Y, Mittal K, Kong B, Kurita T, Wei JJ (2014) MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma. Mod Pathol 27:1144–1153
Bhaskaran K, Douglas I, Forbes H, dos-Santos-Silva I, Leon DA, Smeeth L (2014) Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 384:755–765
Bjorge T, Engeland A, Tretli S, Weiderpass E (2007) Body size in relation to cancer of the uterine corpus in 1 million Norwegian women. Int J Cancer 120:378–383
Bourbon HM (2008) Comparative genomics supports a deep evolutionary origin for the large, four-module transcriptional mediator complex. Nucleic Acids Res 36:3993–4008
Bray GA (2004) Medical consequences of obesity. J Clin Endocrinol Metab 89:2583–2589
Bulun SE (2013) Uterine fibroids. N Engl J Med 369:1344–1355
Buza N, Xu F, Wu W, Carr RJ, Li P, Hui P (2014) Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study. Hum Pathol 45:1885–1892
Cadigan KM (2012) TCFs and Wnt/beta-catenin signaling: more than one way to throw the switch. Curr Top Dev Biol 98:1–34
Cai S, Zhang YX, Han K, Ding YQ (2017) Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma. Arch Gynecol Obstet 296:93–98
Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 348:1625–1638
Cancer Genome Atlas Research N, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R et al (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497:67–73
Carrera I, Janody F, Leeds N, Duveau F, Treisman JE (2008) Pygopus activates wingless target gene transcription through the mediator complex subunits Med12 and Med13. Proc Natl Acad Sci U S A 105:6644–6649
Chen M, Liang J, Ji H, Yang Z, Altilia S, Hu B, Schronce A, McDermott MSJ, Schools GP, Lim CU et al (2017) CDK8/19 mediator kinases potentiate induction of transcription by NFkappaB. Proc Natl Acad Sci U S A 114:10208–10213
Clark AD, Oldenbroek M, Boyer TG (2015) Mediator kinase module and human tumorigenesis. Crit Rev Biochem Mol Biol 50:393–426
Colditz GA, Peterson LL (2018) Obesity and Cancer: evidence, impact, and future directions. Clin Chem 64:154–162
Conaway RC, Conaway JW (2011) Function and regulation of the mediator complex. Curr Opin Genet Dev 21:225–230
Corachan A, Ferrero H, Aguilar A, Garcia N, Monleon J, Faus A, Cervello I, Pellicer A (2019) Inhibition of tumor cell proliferation in human uterine leiomyomas by vitamin D via Wnt/beta-catenin pathway. Fertil Steril 111:397–407
Croce S, Chibon F (2015) MED12 and uterine smooth muscle oncogenesis: state of the art and perspectives. Eur J Cancer 51:1603–1610
Crown J (2017) CDK8: a new breast cancer target. Oncotarget 8:14269–14270
Dannappel MV, Sooraj D, Loh JJ, Firestein R (2018) Molecular and in vivo functions of the CDK8 and CDK19 kinase modules. Front Cell Dev Biol 6:171
David CJ, Massague J (2018) Contextual determinants of TGFbeta action in development, immunity and cancer. Nat Rev Mol Cell Biol 19:419–435
de Graaff MA, Cleton-Jansen AM, Szuhai K, Bovee JV (2013) Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity. Hum Pathol 44:1597–1604
DeBose-Boyd RA, Ye J (2018) SREBPs in lipid metabolism, insulin signaling, and beyond. Trends Biochem Sci 43:358–368
Demetriades C, Doumpas N, Teleman AA (2014) Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell 156:786–799
Desvergne B, Michalik L, Wahli W (2006) Transcriptional regulation of metabolism. Physiol Rev 86:465–514
Di Tommaso S, Tinelli A, Malvasi A, Massari S (2014) Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma. Mol Hum Reprod 20:1009–1015
Donner AJ, Szostek S, Hoover JM, Espinosa JM (2007) CDK8 is a stimulus-specific positive coregulator of p53 target genes. Mol Cell 27:121–133
Dyson N (1998) The regulation of E2F by pRB-family proteins. Genes Dev 12:2245–2262
Edgar BA (2006) How flies get their size: genetics meets physiology. Nat Rev Genet 7:907–916
Eritja N, Yeramian A, Chen BJ, Llobet-Navas D, Ortega E, Colas E, Abal M, Dolcet X, Reventos J, Matias-Guiu X (2017) Endometrial carcinoma: specific targeted pathways. Adv Exp Med Biol 943:149–207
Fant CB, Taatjes DJ (2018) Regulatory functions of the mediator kinases CDK8 and CDK19. Transcription 10:76–90
Felix AS, Yang HP, Bell DW, Sherman ME (2017a) Epidemiology of endometrial carcinoma: etiologic importance of hormonal and metabolic influences. Adv Exp Med Biol 943:3–46
Felix AS, Yang HP, Bell DW, Sherman ME (2017b) Epidemiology of endometrial carcinoma: etiologic importance of hormonal and metabolic influences. In: Ellenson LH (ed) Molecular genetics of endometrial carcinoma, advances in experimental medicine and biology. Springer, Cham, pp 3–46
Feng D, Youn DY, Zhao X, Gao Y, Quinn WJ 3rd, Xiaoli AM, Sun Y, Birnbaum MJ, Pessin JE, Yang F (2015) mTORC1 Down-regulates cyclin-dependent kinase 8 (CDK8) and cyclin C (CycC). PLoS One 10:e0126240
Feng L, Peng Y, Wu P, Hu K, Jiang WD, Liu Y, Jiang J, Li SH, Zhou XQ (2013) Threonine affects intestinal function, protein synthesis and gene expression of TOR in Jian carp (Cyprinus carpio var. Jian). PloS One 8:e69974
Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S et al (2008) CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455:547–551
Fryer CJ, White JB, Jones KA (2004) Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell 16:509–520
Galbraith MD, Allen MA, Bensard CL, Wang X, Schwinn MK, Qin B, Long HW, Daniels DL, Hahn WC, Dowell RD et al (2013) HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. Cell 153:1327–1339
Galindo LJ, Hernandez-Beeftink T, Salas A, Jung Y, Reyes R, de Oca FM, Hernandez M, Almeida TA (2018) HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas. Gynecol Oncol 150:562–568
Gallinetti J, Harputlugil E, Mitchell JR (2013) Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J 449:1–10
Gao X, Xie XJ, Hsu FN, Li X, Liu M, Hemba-Waduge RU, Xu W, Ji JY (2018) CDK8 mediates the dietary effects on developmental transition in Drosophila. Dev Biol 444:62–70
Gao Y, Lin P, Lydon JP, Li Q (2017) Conditional abrogation of transforming growth factor-beta receptor 1 in PTEN-inactivated endometrium promotes endometrial cancer progression in mice. J Pathol 243:89–99
Garofalo RS (2002) Genetic analysis of insulin signaling in Drosophila. Trends Endocrinol Metab 13:156–162
Geminard C, Arquier N, Layalle S, Bourouis M, Slaidina M, Delanoue R, Bjordal M, Ohanna M, Ma M, Colombani J et al (2006) Control of metabolism and growth through insulin-like peptides in Drosophila. Diabetes 55:S5–S8
Goldstein JL, Rawson RB, Brown MS (2002) Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys 397:139–148
Goodwin PJ, Stambolic V (2015) Impact of the obesity epidemic on cancer. Annu Rev Med 66:281–296
Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29:415–445
Gu W, Wang C, Li W, Hsu FN, Tian L, Zhou J, Yuan C, Xie XJ, Jiang T, Addya S et al (2013) Tumor-suppressive effects of CDK8 in endometrial cancer cells. Cell Cycle 12:987–999
Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Manson JE, Li J, Harris TG, Rohan TE, Xue X, Ho GY et al (2008) A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev 17:921–929
Halder G, Mills GB (2011) Drosophila in cancer research: to boldly go where no one has gone before. Oncogene 30:4063–4066
Halder SK, Laknaur A, Miller J, Layman LC, Diamond M, Al-Hendy A (2015) Novel MED12 gene somatic mutations in women from the southern United States with symptomatic uterine fibroids. Mol Genet Genomics 290:505–511
Hamilton KJ, Hewitt SC, Arao Y, Korach KS (2017) Estrogen Hormone Biology. Curr Top Dev Biol 125:109–146
Hayden MA, Ordulu Z, Gallagher CS, Quade BJ, Anchan RM, Middleton NR, Srouji SS, Stewart EA, Morton CC (2018) Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata. Cancer Genet 222–223:1–8
Heikkinen T, Kampjarvi K, Keskitalo S, von Nandelstadh P, Liu X, Rantanen V, Pitkanen E, Kinnunen M, Kuusanmaki H, Kontro M et al (2017) Somatic MED12 nonsense mutation escapes mRNA decay and reveals a motif required for nuclear entry. Hum Mutat 38:269–274
Heinonen HR, Pasanen A, Heikinheimo O, Tanskanen T, Palin K, Tolvanen J, Vahteristo P, Sjoberg J, Pitkanen E, Butzow R et al (2017) Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas. Sci Rep 7:1015
Heinonen HR, Sarvilinna NS, Sjoberg J, Kampjarvi K, Pitkanen E, Vahteristo P, Makinen N, Aaltonen LA (2014) MED12 mutation frequency in unselected sporadic uterine leiomyomas. Fertil Steril 102:1137–1142
Hengartner CJ, Myer VE, Liao SM, Wilson CJ, Koh SS, Young RA (1998) Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol Cell 2:43–53
Hirabayashi S (2016) The interplay between obesity and cancer: a fly view. Dis Model Mech 9:917–926
Holzmann C, Markowski DN, Bartnitzke S, Koczan D, Helmke BM, Bullerdiek J (2015) A rare coincidence of different types of driver mutations among uterine leiomyomas (UL). Mol Cytogenet 8:76
Hruby A, Hu FB (2015) The epidemiology of obesity: A big picture. PharmacoEconomics 33:673–689
Ito M, Okano HJ, Darnell RB, Roeder RG (2002) The TRAP100 component of the TRAP/mediator complex is essential in broad transcriptional events and development. EMBO J 21:3464–3475
Ito M, Yuan CX, Malik S, Gu W, Fondell JD, Yamamura S, Fu ZY, Zhang X, Qin J, Roeder RG (1999) Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol Cell 3:361–370
Iyengar NM, Hudis CA, Dannenberg AJ (2015) Obesity and cancer: local and systemic mechanisms. Annu Rev Med 66:297–309
Jamaluddin MFB, Ko YA, Kumar M, Brown Y, Bajwa P, Nagendra PB, Skerrett-Byrne DA, Hondermarck H, Baker MA, Dun MD et al (2018) Proteomic profiling of human uterine fibroids reveals upregulation of the extracellular matrix protein Periostin. Endocrinology 159:1106–1118
Je EM, Kim MR, Min KO, Yoo NJ, Lee SH (2012) Mutational analysis of MED12 exon 2 in uterine leiomyoma and other common tumors. Int J Cancer 131:E1044–E1047
Ji JY, Dyson NJ (2010) Interplay between cyclin-dependent kinases and E2F-dependent transcription. In: Enders G (ed) Cell cycle deregulation in cancer. Springer, New York, pp 23–41
Jiang P, Hu Q, Ito M, Meyer S, Waltz S, Khan S, Roeder RG, Zhang X (2010) Key roles for MED1 LxxLL motifs in pubertal mammary gland development and luminal-cell differentiation. Proc Natl Acad Sci U S A 107:6765–6770
Joshi A, Miller C Jr, Baker SJ, Ellenson LH (2015) Activated mutant p110alpha causes endometrial carcinoma in the setting of biallelic Pten deletion. Am J Pathol 185:1104–1113
Kampjarvi K, Jarvinen TM, Heikkinen T, Ruppert AS, Senter L, Hoag KW, Dufva O, Kontro M, Rassenti L, Hertlein E et al (2015) Somatic MED12 mutations are associated with poor prognosis markers in chronic lymphocytic leukemia. Oncotarget 6:1884–1888
Kampjarvi K, Kim NH, Keskitalo S, Clark AD, von Nandelstadh P, Turunen M, Heikkinen T, Park MJ, Makinen N, Kivinummi K et al (2016) Somatic MED12 mutations in prostate cancer and uterine leiomyomas promote tumorigenesis through distinct mechanisms. Prostate 76:22–31
Kampjarvi K, Makinen N, Kilpivaara O, Arola J, Heinonen HR, Bohm J, Abdel-Wahab O, Lehtonen HJ, Pelttari LM, Mehine M et al (2012) Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer. Br J Cancer 107:1761–1765
Kampjarvi K, Park MJ, Mehine M, Kim NH, Clark AD, Butzow R, Bohling T, Bohm J, Mecklin JP, Jarvinen H et al (2014) Mutations in exon 1 highlight the role of MED12 in uterine leiomyomas. Hum Mutat 35:1136–1141
Kapoor A, Goldberg MS, Cumberland LK, Ratnakumar K, Segura MF, Emanuel PO, Menendez S, Vardabasso C, Leroy G, Vidal CI et al (2010) The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature 468:1105–1109
Kato Y, Habas R, Katsuyama Y, Naar AM, He X (2002) A component of the ARC/mediator complex required for TGF beta/nodal signalling. Nature 418:641–646
Kim JJ, Chapman-Davis E (2010) Role of progesterone in endometrial cancer. Semin Reprod Med 28:81–90
Kim S, Xu X, Hecht A, Boyer TG (2006) Mediator is a transducer of Wnt/beta-catenin signaling. J Biol Chem 281:14066–14075
Knuesel MT, Meyer KD, Donner AJ, Espinosa JM, Taatjes DJ (2009) The human CDK8 subcomplex is a histone kinase that requires Med12 for activity and can function independently of mediator. Mol Cell Biol 29:650–661
Koehler MF, Bergeron P, Blackwood EM, Bowman K, Clark KR, Firestein R, Kiefer JR, Maskos K, McCleland ML, Orren L et al (2016) Development of a potent, specific CDK8 kinase inhibitor which Phenocopies CDK8/19 knockout cells. ACS Med Chem Lett 7:223–228
Kornberg RD (2005) Mediator and the mechanism of transcriptional activation. Trends Biochem Sci 30:235–239
Kriseman M, Monsivais D, Agno J, Masand RP, Creighton CJ, Matzuk MM (2019) Uterine double-conditional inactivation of Smad2 and Smad3 in mice causes endometrial dysregulation, infertility, and uterine cancer. Proc Natl Acad Sci U S A 116:3873–3882
Kuuluvainen E, Hakala H, Havula E, Sahal Estime M, Ramet M, Hietakangas V, Makela TP (2014) Cyclin-dependent kinase 8 module expression profiling reveals requirement of mediator subunits 12 and 13 for transcription of serpent-dependent innate immunity genes in Drosophila. J Biol Chem 289:16252–16261
Lansard M, Panserat S, Plagnes-Juan E, Dias K, Seiliez I, Skiba-Cassy S (2011) L-leucine, L-methionine, and L-lysine are involved in the regulation of intermediary metabolism-related gene expression in rainbow trout hepatocytes. J Nutr 141:75–80
Laplante M, Sabatini DM (2009) An emerging role of mTOR in lipid biosynthesis. Curr Biol 19:R1046–R1052
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, and International Agency for Research on Cancer Handbook Working, G (2016) Body fatness and cancer – viewpoint of the IARC Working Group. N Engl J Med 375:794–798
Lax SF (2017) Pathology of endometrial carcinoma. Adv Exp Med Biol 943:75–96
Leclerc V, Tassan JP, O’Farrell PH, Nigg EA, Leopold P (1996) Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II. Mol Biol Cell 7:505–513
Lee JH, Bassel-Duby R, Olson EN (2014) Heart- and muscle-derived signaling system dependent on MED13 and wingless controls obesity in Drosophila. Proc Natl Acad Sci U S A 111:9491–9496
Lee M, Cheon K, Chae B, Hwang H, Kim HK, Chung YJ, Song JY, Cho HH, Kim JH, Kim MR (2018) Analysis of MED12 mutation in multiple uterine leiomyomas in South Korean patients. Int J Med Sci 15:124–128
Li Q (2019) Tumor-suppressive signaling in the uterus. Proc Natl Acad Sci U S A 116:3367–3369
Li, X., Liu, M., Ren, X., Loncle, N., Wang, Q., Hemba-Waduge, R., Boube, M., Bourbon, H.-M. G., Ni, J.Q., and Ji, J.Y. (2018a). The mediator CDK8-Cyclin C complex modulates vein patterning in Drosophila by stimulating Mad-dependent transcription. BioRxiv https://doi.org/10.1101/360628
Li Z, Maeda D, Kudo-Asabe Y, Tamura D, Nanjo H, Hayashi A, Ikemura M, Fukayama M, Goto A (2018b) MED12 is frequently mutated in ovarian and other adnexal leiomyomas. Hum Pathol 81:89–95
Liegl-Atzwanger B, Heitzer E, Flicker K, Muller S, Ulz P, Saglam O, Tavassoli F, Devouassoux-Shisheboran M, Geigl J, Moinfar F (2016) Exploring chromosomal abnormalities and genetic changes in uterine smooth muscle tumors. Mod Pathol 29:1262–1277
Lim WK, Ong CK, Tan J, Thike AA, Ng CC, Rajasegaran V, Myint SS, Nagarajan S, Nasir ND, McPherson JR et al (2014) Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma. Nat Genet 46:877–880
Lindemann K, Vatten LJ, Ellstrom-Engh M, Eskild A (2009) The impact of BMI on subgroups of uterine cancer. Br J Cancer 101:534–536
Lu KH, Wu W, Dave B, Slomovitz BM, Burke TW, Munsell MF, Broaddus RR, Walker CL (2008) Loss of tuberous sclerosis complex-2 function and activation of mammalian target of rapamycin signaling in endometrial carcinoma. Clin Cancer Res 14:2543–2550
Lukanova A, Bjor O, Kaaks R, Lenner P, Lindahl B, Hallmans G, Stattin P (2006) Body mass index and cancer: results from the northern Sweden health and disease cohort. Int J Cancer 118:458–466
Lundqvist E, Kaprio J, Verkasalo PK, Pukkala E, Koskenvuo M, Soderberg KC, Feychting M (2007) Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. Int J Cancer 121:810–818
Lynch CJ, Adams SH (2014) Branched-chain amino acids in metabolic signalling and insulin resistance. Nat Rev Endocrinol 10:723–736
Makinen N, Aavikko M, Heikkinen T, Taipale M, Taipale J, Koivisto-Korander R, Butzow R, Vahteristo P (2016) Exome sequencing of uterine Leiomyosarcomas identifies frequent mutations in TP53, ATRX, and MED12. PLoS Genet 12:e1005850
Makinen N, Heinonen HR, Moore S, Tomlinson IP, van der Spuy ZM, Aaltonen LA (2011a) MED12 exon 2 mutations are common in uterine leiomyomas from south African patients. Oncotarget 2:966–969
Makinen N, Heinonen HR, Sjoberg J, Taipale J, Vahteristo P, Aaltonen LA (2014) Mutation analysis of components of the mediator kinase module in MED12 mutation-negative uterine leiomyomas. Br J Cancer 110:2246–2249
Makinen N, Kampjarvi K, Frizzell N, Butzow R, Vahteristo P (2017) Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors. Mol Cancer 16:101
Makinen N, Mehine M, Tolvanen J, Kaasinen E, Li Y, Lehtonen HJ, Gentile M, Yan J, Enge M, Taipale M et al (2011b) MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas. Science 334:252–255
Malik S, Roeder RG (2010) The metazoan mediator co-activator complex as an integrative hub for transcriptional regulation. Nat Rev Genet 11:761–772
Markowski DN, Bartnitzke S, Loning T, Drieschner N, Helmke BM, Bullerdiek J (2012) MED12 mutations in uterine fibroids--their relationship to cytogenetic subgroups. Int J Cancer 131:1528–1536
Massague J (2008) TGFbeta in Cancer. Cell 134:215–230
Matsubara A, Sekine S, Yoshida M, Yoshida A, Taniguchi H, Kushima R, Tsuda H, Kanai Y (2013) Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours. Histopathology 62:657–661
McCleland ML, Soukup TM, Liu SD, Esensten JH, de Sousa EMF, Yaylaoglu M, Warming S, Roose-Girma M, Firestein R (2015) Cdk8 deletion in the Apc(Min) murine tumour model represses EZH2 activity and accelerates tumourigenesis. J Pathol 237:508–519
McConechy MK, Ding J, Cheang MC, Wiegand K, Senz J, Tone A, Yang W, Prentice L, Tse K, Zeng T et al (2012) Use of mutation profiles to refine the classification of endometrial carcinomas. J Pathol 228:20–30
McDermott MS, Chumanevich AA, Lim CU, Liang J, Chen M, Altilia S, Oliver D, Rae JM, Shtutman M, Kiaris H et al (2017) Inhibition of CDK8 mediator kinase suppresses estrogen dependent transcription and the growth of estrogen receptor positive breast cancer. Oncotarget 8:12558–12575
McGuire MM, Yatsenko A, Hoffner L, Jones M, Surti U, Rajkovic A (2012) Whole exome sequencing in a random sample of north American women with leiomyomas identifies MED12 mutations in majority of uterine leiomyomas. PLoS One 7:e33251
Mehine M, Kaasinen E, Heinonen HR, Makinen N, Kampjarvi K, Sarvilinna N, Aavikko M, Vaharautio A, Pasanen A, Butzow R et al (2016) Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A 113:1315–1320
Mehine M, Kaasinen E, Makinen N, Katainen R, Kampjarvi K, Pitkanen E, Heinonen HR, Butzow R, Kilpivaara O, Kuosmanen A et al (2013) Characterization of uterine leiomyomas by whole-genome sequencing. N Engl J Med 369:43–53
Mehine M, Makinen N, Heinonen HR, Aaltonen LA, Vahteristo P (2014) Genomics of uterine leiomyomas: insights from high-throughput sequencing. Fertil Steril 102:621–629
Mello JBH, Barros-Filho MC, Abreu FB, Cirilo PDR, Domingues MAC, Pontes A, Rogatto SR (2018) MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma. Mol Hum Reprod 24:556–563
Meyer KD, Lin SC, Bernecky C, Gao Y, Taatjes DJ (2010) p53 activates transcription by directing structural shifts in mediator. Nat Struct Mol Biol 17:753–760
Mittal P, Shin YH, Yatsenko SA, Castro CA, Surti U, Rajkovic A (2015) Med12 gain-of-function mutation causes leiomyomas and genomic instability. J Clin Invest 125:3280–3284
Monsivais D, Peng J, Kang Y, Matzuk MM (2019) Activin-like kinase 5 (ALK5) inactivation in the mouse uterus results in metastatic endometrial carcinoma. Proc Natl Acad Sci U S A 116:3883–3892
Moravek MB, Bulun SE (2015) Endocrinology of uterine fibroids: steroid hormones, stem cells, and genetic contribution. Curr Opin Obstet Gynecol 27:276–283
Morris EJ, Ji JY, Yang F, Di Stefano L, Herr A, Moon NS, Kwon EJ, Haigis KM, Naar AM, Dyson NJ (2008) E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. Nature 455:552–556
Nagasawa S, Maeda I, Fukuda T, Wu W, Hayami R, Kojima Y, Tsugawa K, Ohta T (2015) MED12 exon 2 mutations in phyllodes tumors of the breast. Cancer Med 4:1117–1121
Neishabouri SH, Hutson SM, Davoodi J (2015) Chronic activation of mTOR complex 1 by branched chain amino acids and organ hypertrophy. Amino Acids 47:1167–1182
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF et al (2014) Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease Study 2013. Lancet 384:766–781
Nusse R, Clevers H (2017) Wnt/beta-catenin signaling, disease, and emerging therapeutic modalities. Cell 169:985–999
Oh JC, Wu W, Tortolero-Luna G, Broaddus R, Gershenson DM, Burke TW, Schmandt R, Lu KH (2004) Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 13:748–752
Osborne TF, Espenshade PJ (2009) Evolutionary conservation and adaptation in the mechanism that regulates SREBP action: what a long, strange tRIP it’s been. Genes Dev 23:2578–2591
Osherovich L (2008) CDK8 is enough in colorectal cancer Science-Business eXchange 1:5–7
Osinovskaya NS, Malysheva OV, Shved NY, Ivashchenko TE, Sultanov IY, Efimova OA, Yarmolinskaya MI, Bezhenar VF, Baranov VS (2016) Frequency and Spectrum of MED12 exon 2 mutations in multiple versus solitary uterine leiomyomas from Russian patients. Int J Gynecol Pathol 35:509–515
Park MJ, Shen H, Kim NH, Gao F, Failor C, Knudtson JF, McLaughlin J, Halder SK, Heikkinen TA, Vahteristo P et al (2018a) Mediator kinase disruption in MED12-mutant uterine fibroids from Hispanic Women of South Texas. J Clin Endocrinol Metab 103:4283–4292
Park MJ, Shen H, Spaeth JM, Tolvanen JH, Failor C, Knudtson JF, McLaughlin J, Halder SK, Yang Q, Bulun SE et al (2018b) Oncogenic exon 2 mutations in mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19. J Biol Chem 293:4870–4882
Paul PG, Gulati G, Shintre H, Mannur S, Paul G, Mehta S (2018) Extrauterine adenomyoma: a review of the literature. Eur J Obstet Gynecol Reprod Biol 228:130–136
Pavone D, Clemenza S, Sorbi F, Fambrini M, Petraglia F (2018) Epidemiology and risk factors of uterine fibroids. Best Pract Res Clin Obstet Gynaecol 46:3–11
Pelish HE, Liau BB, Nitulescu II, Tangpeerachaikul A, Poss ZC, Da Silva DH, Caruso BT, Arefolov A, Fadeyi O, Christie AL et al (2015) Mediator kinase inhibition further activates super-enhancer-associated genes in AML. Nature 526:273–276
Perot G, Croce S, Ribeiro A, Lagarde P, Velasco V, Neuville A, Coindre JM, Stoeckle E, Floquet A, MacGrogan G et al (2012) MED12 alterations in both human benign and malignant uterine soft tissue tumors. PLoS One 7:e40015
Philip S, Kumarasiri M, Teo T, Yu M, Wang S (2018) Cyclin-dependent kinase 8: A new Hope in targeted Cancer therapy? J Med Chem 61:5073–5092
Pi-Sunyer X (2009) The medical risks of obesity. Postgrad Med 121:21–33
Podsypanina K, Ellenson LH, Nemes A, Gu J, Tamura M, Yamada KM, Cordon-Cardo C, Catoretti G, Fisher PE, Parsons R (1999) Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proc Natl Acad Sci U S A 96:1563–1568
Pon JR, Marra MA (2015) Driver and passenger mutations in cancer. Annu Rev Pathol 10:25–50
Potter CJ, Turenchalk GS, Xu T (2000) Drosophila in cancer research. An expanding role. Trends Genet 16:33–39
Quinn WJ 3rd, Birnbaum MJ (2012) Distinct mTORC1 pathways for transcription and cleavage of SREBP-1c. Proc Natl Acad Sci U S A 109:15974–15975
Raftery LA, Sutherland DJ (1999) TGF-beta family signal transduction in Drosophila development: from mad to Smads. Dev Biol 210:251–268
Raj N, Attardi LD (2017) The transactivation domains of the p53 protein. Cold Spring Harb Perspect Med 7:a026047
Ramirez PT, Mundt AJ, Muggia FM (2011) Cancers of the uterine body, 9th edn (LWW)
Rapp K, Schroeder J, Klenk J, Stoehr S, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK (2005) Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria. Br J Cancer 93:1062–1067
Ravegnini G, Marino-Enriquez A, Slater J, Eilers G, Wang Y, Zhu M, Nucci MR, George S, Angelini S, Raut CP et al (2013) MED12 mutations in leiomyosarcoma and extrauterine leiomyoma. Mod Pathol 26:743–749
Rawson RB (2003) The SREBP pathway--insights from Insigs and insects. Nat Rev Mol Cell Biol 4:631–640
Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D, Million Women Study C (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134
Renehan AG, Frystyk J, Flyvbjerg A (2006) Obesity and cancer risk: the role of the insulin-IGF axis. Trends Endocrinol Metab 17:328–336
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371:569–578
Restrepo S, Zartman JJ, Basler K (2014) Coordination of patterning and growth by the morphogen DPP. Curr Biol 24:R245–R255
Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT (1986) Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J 293:359–362
Rudrapatna VA, Cagan RL, Das TK (2012) Drosophila cancer models. Dev Dyn 241:107–118
Rzymski T, Mikula M, Wiklik K, Brzozka K (2015) CDK8 kinase--an emerging target in targeted cancer therapy. Biochim Biophys Acta 1854:1617–1629
Sabatini DM (2017) Twenty-five years of mTOR: uncovering the link from nutrients to growth. Proc Natl Acad Sci U S A 114:11818–11825
Sadeghi S, Khorrami M, Amin-Beidokhti M, Abbasi M, Kamalian Z, Irani S, Omrani M, Azmoodeh O, Mirfakhraie R (2016) The study of MED12 gene mutations in uterine leiomyomas from Iranian patients. Tumour Biol 37:1567–1571
Saltiel AR, Olefsky JM (2017) Inflammatory mechanisms linking obesity and metabolic disease. J Clin Invest 127:1–4
Schiano C, Casamassimi A, Rienzo M, de Nigris F, Sommese L, Napoli C (2014a) Involvement of mediator complex in malignancy. Biochim Biophys Acta 1845:66–83
Schiano C, Casamassimi A, Vietri MT, Rienzo M, Napoli C (2014b) The roles of mediator complex in cardiovascular diseases. Biochim Biophys Acta 1839:444–451
Schwetye KE, Pfeifer JD, Duncavage EJ (2014) MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors. Hum Pathol 45:65–70
Senior K (2002) Drosophila still flying high in cancer research. Lancet 359:952
Serna VA, Wu X, Qiang W, Thomas J, Blumenfeld ML, Kurita T (2018) Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo. Endocr Relat Cancer 25:747–759
Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM et al (2013) Type I and II endometrial cancers: have they different risk factors? J Clin Oncol Off J Am Soc Clin Oncol 31:2607–2618
Shahbazi S, Fatahi N, Amini-Moghaddam S (2015) Somatic mutational analysis of MED12 exon 2 in uterine leiomyomas of Iranian women. Am J Cancer Res 5:2441–2446
Shao W, Espenshade PJ (2012) Expanding roles for SREBP in metabolism. Cell Metab 16:414–419
Siraj AK, Masoodi T, Bu R, Pratheeshkumar P, Al-Sanea N, Ashari LH, Abduljabbar A, Alhomoud S, Al-Dayel F, Alkuraya FS et al (2018) MED12 is recurrently mutated in middle eastern colorectal cancer. Gut 67:663–671
Song Z, Xiaoli AM, Yang F (2018) Regulation and metabolic significance of De novo lipogenesis in adipose tissues. Nutrients 10:E1383
Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B (2016) Uterine fibroids. Nat Rev Dis Primers 2:16043
Styer AK, Rueda BR (2016) The epidemiology and genetics of uterine leiomyoma. Best Pract Res Clin Obstet Gynaecol 34:3–12
Tahlan A, Nanda A, Mohan H (2006) Uterine adenomyoma: a clinicopathologic review of 26 cases and a review of the literature. Int J Gynecol Pathol 25:361–365
Tan WJ, Chan JY, Thike AA, Lim JC, Md Nasir ND, Tan JS, Koh VC, Lim WK, Tan J, Ng CC et al (2016) MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression. J Clin Pathol 69:858–865
Tang HW, Hu Y, Chen CL, Xia B, Zirin J, Yuan M, Asara JM, Rabinow L, Perrimon N (2018) The TORC1-regulated CPA complex rewires an RNA processing network to drive autophagy and metabolic reprogramming. Cell Metab 27(1040–1054):e1048
Tassan JP, Jaquenoud M, Leopold P, Schultz SJ, Nigg EA (1995) Identification of human cyclin-dependent kinase 8, a putative protein kinase partner for cyclin C. Proc Natl Acad Sci U S A 92:8871–8875
Terriente-Felix A, Lopez-Varea A, de Celis JF (2010) Identification of genes affecting wing patterning through a loss-of-function mutagenesis screen and characterization of med15 function during wing development. Genetics 185:671–684
Tipping M, Perrimon N (2014) Drosophila as a model for context-dependent tumorigenesis. J Cell Physiol 229:27–33
Tsai KL, Sato S, Tomomori-Sato C, Conaway RC, Conaway JW, Asturias FJ (2013) A conserved mediator-CDK8 kinase module association regulates mediator-RNA polymerase II interaction. Nat Struct Mol Biol 20:611–619
Turunen M, Spaeth JM, Keskitalo S, Park MJ, Kivioja T, Clark AD, Makinen N, Gao F, Palin K, Nurkkala H et al (2014) Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activity. Cell Rep 7:654–660
Upadhyay A, Moss-Taylor L, Kim MJ, Ghosh AC, O’Connor MB (2017) TGF-beta family signaling in Drosophila. Cold Spring Harb Perspect Biol 9:a022152
Valenta T, Hausmann G, Basler K (2012) The many faces and functions of beta-catenin. EMBO J 31:2714–2736
Valladares F, Frias I, Baez D, Garcia C, Lopez FJ, Fraser JD, Rodriguez Y, Reyes R, Diaz-Flores L, Bello AR (2006) Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells. Fertil Steril 86:1736–1743
Vasquez YM (2018) Estrogen-regulated transcription: mammary gland and uterus. Steroids 133:82–86
Verit FF, Yucel O (2013) Endometriosis, leiomyoma and adenomyosis: the risk of gynecologic malignancy. Asian Pac J Cancer Prev 14:5589–5597
Vidal M, Cagan RL (2006) Drosophila models for cancer research. Curr Opin Genet Dev 16:10–16
Wang H, Ye J, Qian H, Zhou R, Jiang J, Ye L (2015) High-resolution melting analysis of MED12 mutations in uterine leiomyomas in Chinese patients. Genet Test Mol Biomarkers 19:162–166
Weber H, Garabedian MJ (2018) The mediator complex in genomic and non-genomic signaling in cancer. Steroids 133:8–14
Weiderpass E, Brismar K, Bellocco R, Vainio H, Kaaks R (2003) Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. Br J Cancer 89:1697–1704
White PJ, Newgard CB (2019) Branched-chain amino acids in disease. Science 363:582–583
Wu B, Slabicki M, Sellner L, Dietrich S, Liu X, Jethwa A, Hullein J, Walther T, Wagner L, Huang Z et al (2017a) MED12 mutations and NOTCH signalling in chronic lymphocytic leukaemia. Br J Haematol 179:421–429
Wu J, Zou Y, Luo Y, Guo JB, Liu FY, Zhou JY, Zhang ZY, Wan L, Huang OP (2017b) Prevalence and clinical significance of mediator complex subunit 12 mutations in 362 Han Chinese samples with uterine leiomyoma. Oncol Lett 14:47–54
Xie XJ, Hsu FN, Gao X, Xu W, Ni JQ, Xing Y, Huang L, Hsiao HC, Zheng H, Wang C et al (2015) CDK8-cyclin C mediates nutritional regulation of developmental transitions through the ecdysone receptor in Drosophila. PLoS Biol 13:e1002207
Xu P, Lin X, Feng XH (2016) Posttranslational regulation of Smads. Cold Spring Harb Perspect Biol 8:a022087
Xu W, Ji JY (2011) Dysregulation of CDK8 and cyclin C in tumorigenesis. J Genet Genomics 38:439–452
Yang F, Vought BW, Satterlee JS, Walker AK, Jim Sun ZY, Watts JL, DeBeaumont R, Saito RM, Hyberts SG, Yang S et al (2006) An ARC/mediator subunit required for SREBP control of cholesterol and lipid homeostasis. Nature 442:700–704
Yatsenko SA, Mittal P, Wood-Trageser MA, Jones MW, Surti U, Edwards RP, Sood AK, Rajkovic A (2017) Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays. Fertil Steril 107(457–466):e459
Yergiyev O, Garib G, Schoedel K, Palekar A, Bartlett D, Rao UNM (2018) CDK8 expression in Extrauterine Leiomyosarcoma correlates with tumor stage and progression. Appl Immunohistochem Mol Morphol 26:161–164
Yoda A, Kouike H, Okano H, Sawa H (2005) Components of the transcriptional mediator complex are required for asymmetric cell division in C. elegans. Development 132:1885–1893
Yoon MS (2016) The emerging role of branched-chain amino acids in insulin resistance and metabolism. Nutrients 8:E405
Zhai Y, Sun Z, Zhang J, Kang K, Chen J, Zhang W (2015) Activation of the TOR Signalling pathway by glutamine regulates insect fecundity. Sci Rep 5:10694
Zhang Q, Ubago J, Li L, Guo H, Liu Y, Qiang W, Kim JJ, Kong B, Wei JJ (2014) Molecular analyses of 6 different types of uterine smooth muscle tumors: emphasis in atypical leiomyoma. Cancer 120:3165–3177
Zhang S, Zeng X, Ren M, Mao X, Qiao S (2017) Novel metabolic and physiological functions of branched chain amino acids: a review. J Anim Sci Biotechnol 8:10
Zhao J, Ramos R, Demma M (2013) CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation. Oncogene 32:3520–3530
Zhao X, Feng D, Wang Q, Abdulla A, Xie XJ, Zhou J, Sun Y, Yang ES, Liu LP, Vaitheesvaran B et al (2012) Regulation of lipogenesis by cyclin-dependent kinase 8-mediated control of SREBP-1. J Clin Invest 122:2417–2427
Dossus L, Rinaldi S, Becker S, Lukanova A, Tjonneland A, Olsen A, Stegger J, Overvad K, Chabbert-Buffet N, Jimenez-Corona A, Clavel-Chapelon F, Rohrmann S, Teucher B, Boeing H, Schütze M, Trichopoulou A, Benetou V, Lagiou P, Palli D, Berrino F, Panico S, Tumino R, Sacerdote C, Redondo M-L, Travier N, Sanchez M-J, Altzibar JM, Chirlaque M-D, Ardanaz E, Bueno-de-Mesquita HB, van Duijnhoven FJB, Onland-Moret NC, Peeters PHM, Hallmans G, Lundin E, Khaw K-T, Wareham N, Allen N, Key TJ, Slimani N, Hainaut P, Romaguera D, Norat T, Riboli E, Kaaks R Obesity, inflammatory markers, and endometrial cancer risk: a prospective case–control study. Endocr Relat Cancer 17(4):1007–1019
Acknowledgments
We apologize to those colleagues whose work is not cited in this essay due to space limitations or our ignorance and negligence. This work was supported in part by NIH grants R01DK095013 and R01GM129266.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Li, X., Liu, M., Ji, JY. (2019). Understanding Obesity as a Risk Factor for Uterine Tumors Using Drosophila. In: Deng, WM. (eds) The Drosophila Model in Cancer. Advances in Experimental Medicine and Biology, vol 1167. Springer, Cham. https://doi.org/10.1007/978-3-030-23629-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-23629-8_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-23628-1
Online ISBN: 978-3-030-23629-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)